Analysis of the additional data and information submitted by Bharat Biotech and Serum Institute of India (SII) is still being conducted by the regulator Central Drug Standard Control Organisation's (CDSCO) Subject Expert Committee.
from Medindia Health News https://ift.tt/3o1YCwx
No comments:
Post a Comment